Cargando…
Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention
Griffithsin (GRFT) has shown potent anti-HIV activity, and it is being developed as a drug candidate for HIV prevention. Successful implementation requires thorough understanding of its preformulation characterization. In this work, preformulation assessments were conducted to characterize GRFT and...
Autores principales: | Kramzer, Lindsay F., Hamorsky, Krystal T., Graebing, Phillip W., Wang, Lin, Fuqua, Joshua L., Matoba, Nobuyuki, Lasnik, Amanda B., Moncla, Bernard J., Zhang, Junmei, Palmer, Kenneth E., Rohan, Lisa C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903873/ https://www.ncbi.nlm.nih.gov/pubmed/33625602 http://dx.doi.org/10.1208/s12249-021-01931-0 |
Ejemplares similares
-
Bulk production of the antiviral lectin griffithsin
por: Fuqua, Joshua L., et al.
Publicado: (2015) -
Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis
por: Nabeta, Henry W., et al.
Publicado: (2022) -
Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin
por: Nabeta, Henry W., et al.
Publicado: (2021) -
Improving the large scale purification of the HIV microbicide, griffithsin
por: Fuqua, Joshua L, et al.
Publicado: (2015) -
Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses
por: Kouokam, Joseph Calvin, et al.
Publicado: (2016)